6505--Loperamide Capsules (VA-25-00032225)
ID: 36E79725R0025Type: Solicitation
AwardedJul 7, 2025
$7.8M$7,791,248
AwardeeGOLDEN STATE MEDICAL SUPPLY, INC. CAMARILLO 93012
Award #:36E79725D0048
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/33a1040e238d435c96275bb07dd66e2d/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Loperamide Hydrochloride (HCL) 2mg capsules, as outlined in solicitation number 36E79725R0025. Offerors must provide pricing for a base year and four additional one-year options, including a 0.5% Cost Recovery Fee and unique 11-digit National Drug Codes (NDC) for their products, while adhering to regulatory standards such as the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This procurement is crucial for ensuring the availability of essential pharmaceutical products to VA facilities and other government health service providers. The deadline for proposal submissions has been extended to April 30, 2025, at 2:30 PM Central Time, and interested parties should contact Contract Specialist Nicholas I McGregor at Nicholas.McGregor@va.gov for further information.

    Point(s) of Contact
    Nicholas I McGregorContract Specialist
    Nicholas.McGregor@va.gov
    Files
    Title
    Posted
    36E79725R0025_1.docx
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0025 to procure Loperamide HCL 2MG Capsules. This unrestricted procurement targets not only the VA but also includes the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), with an intention to award one contract to ensure a consistent supply of the medication. The contract will span one year with four optional one-year extensions. Offerors must provide the exact drug name as labeled and a unique National Drug Code (NDC) number. The solicitation is expected to be electronically issued by April 17, 2025, with responses due by May 1, 2025. Estimated requirements include a total of 18,690 bottles of 100 capsules and 47,289 bottles of 500 capsules annually. The announcement emphasizes that interested parties must check the SAM.gov website for updates and that no paper copies of solicitation documents will be distributed. The point of contact for this procurement is Contracting Officer Andrew Cazares, who is available for inquiries via email. This presolicitation reflects the VA’s commitment to maintaining a steady supply of essential medications for its healthcare facilities.
    36E79725R0025.docx
    The document is a solicitation for contract services from the Department of Veterans Affairs (VA) intended to establish a supply source for pharmaceutical products, specifically Loperamide Hydrochloride capsules. The bid includes the base year and four one-year option periods, with requirements for price submissions and compliance with various regulations, including the Drug Supply Chain Security Act (DSCSA). Offerors must submit unique National Drug Codes (NDC) and demonstrate compliance with Good Manufacturing Practices (cGMP) as certified by the FDA. The contract aims to facilitate pharmaceutical distribution to VA facilities, the Department of Defense, and other government health service providers through a network of Prime Vendors. The pricing structure involves a 0.5% Cost Recovery Fee, and contractors must adhere to transparency requirements regarding quarterly sales reporting. Additionally, proper packaging, labeling, and adherence to quality standards are emphasized to ensure safety and regulatory compliance prior to delivery. This solicitation illustrates the government's structured approach to procure pharmaceuticals while ensuring product safety, quality, and compliance with federal laws, demonstrating its commitment to provide healthcare services to veterans and other authorized users effectively.
    36E79725R0025 0001.docx
    The document outlines an amendment to a solicitation issued by the Department of Veterans Affairs (VA) for pharmaceutical products, specifically Loperamide Hydrochloride (HCL) 2mg capsules. The amendment corrects the solicitation posting date and clarifies the due date for proposals, which is set for April 23, 2025, at 2:30 PM Central Time. Offerors are required to submit a signed copy of the amendment and the corrected SF 1449 form with their proposals. Furthermore, the document specifies that to qualify for the award, bidders must provide pricing for the base year and four additional one-year options for all line items. Notably, prices must include a Cost Recovery Fee of 0.5% and must list an 11-digit NDC number unique to the offeror's company. This solicitation reflects the government's commitment to procurement transparency and adherence to regulatory standards for healthcare service supplies, reinforcing the VA's focus on efficient sourcing for its healthcare needs.
    36E79725R0025 0002.docx
    This government document is an amendment to solicitation number 36E79725R0025, issued by the Department of Veterans Affairs for Loperamide HCL Capsules. The primary purpose of the amendment is to extend the deadline for submission of proposals from April 23, 2025, to April 30, 2025, at 2:30 PM Central Time. Offerors are required to acknowledge receipt of the amendment by including a signed copy with their proposals. Despite the deadline extension, all other terms and conditions of the original solicitation remain unchanged. This amendment reflects typical procedures in government Requests for Proposals (RFPs), ensuring that potential contractors are adequately informed and can submit their offers within the new timeframe. The tone is formal and procedural, adhering to government standards for RFP modifications.
    Similar Opportunities
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    6505--Nicotine Lozenges MINI (VA-26-00020754)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Nicotine Mini Lozenges, specifically under solicitation number 36E79726R0007. This contract aims to ensure an uninterrupted supply of nicotine lozenges for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with a contract duration of one year and four optional one-year extensions. The estimated annual requirements include 166,791 bottles of 2mg lozenges and 138,276 bottles of 4mg lozenges, which will be distributed through the VA and DOD Pharmaceutical Prime Vendor Programs. Interested offerors should note that the solicitation will be electronically issued around December 18, 2025, with a tentative closing date of January 1, 2026, and can direct inquiries to Billy Fong at billy.fong@va.gov or by phone at 708-786-4992.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.